Stay updated on TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH announcement about website updates and terminology appears above the study record page’s 403 error.
    Difference
    1%
    Check dated 2026-10-24T14:40:12.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov site revision number changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:30:30.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1; the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:38:54.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study content. This prevents access to the ClinicalTrials.gov record for the NCT03115801 study, hindering users from viewing details.
    Difference
    19%
    Check dated 2026-09-19T18:36:56.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.6.6' was added and the previous tag 'Revision: v3.6.5' was removed, indicating an update to the page's version tag.
    Difference
    0.1%
    Check dated 2026-08-29T19:06:26.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page now presents the full study record for the trial, including the overview, interventions, and outcomes, and adds the Study Protocol/Statistical Analysis Plan document. It replaces the prior error page, restoring access to essential information.
    Difference
    56%
    Check dated 2026-08-15T12:17:26.000Z thumbnail image

Stay in the know with updates to TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.